Disparities in cardiovascular disease mortality after breast cancer treatment: methodological considerations using real-world data Published December 2021 Citation Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K. . Cancer. . https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.34045 Authors:Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K Sources:Cancer Share Posted inPublicationsHealth equityBreast cancer More publicationsSABCSDecember 2025Racial/ethnic inequities in access to novel therapies and outcomes in triple negative breast cancerMbah O, Ho G, Keane C, Dolor A, Ryals C.Publication summaryPublicationsHealth equityBreast cancerASCO Annual MeetingMay 2026Real-world post-progression outcomes following 1L ribociclib + aromatase inhibitor (AI) versus Al alone in African American and low socio-economic status patients with HR+/HER2- mBC in USGadi VK, Hart LL, Tarantino P, et al.Publication summaryPublicationsPrecision medicineHealth equityMetastatic breast cancerASCO Annual MeetingMay 2026Recurrence risk prediction using a large, multi-site observational dataset of patients with early breast cancer including early-onset diseaseBouzit L, Rios G, Karwa S, Fidyk E, Keane C, Estevez M.Publication summaryPublicationsBreast cancerArtificial intelligence